ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

POLX Polarean Imaging Plc

3.90
-0.10 (-2.50%)
17 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Polarean Imaging Plc LSE:POLX London Ordinary Share GB00BF3DT583 ORD GBP0.00037
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -2.50% 3.90 3.80 4.00 3.90 3.90 3.90 396,450 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 1.03M -13.91M -0.0644 -0.61 8.42M
Polarean Imaging Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker POLX. The last closing price for Polarean Imaging was 4p. Over the last year, Polarean Imaging shares have traded in a share price range of 3.72p to 32.25p.

Polarean Imaging currently has 215,848,593 shares in issue. The market capitalisation of Polarean Imaging is £8.42 million. Polarean Imaging has a price to earnings ratio (PE ratio) of -0.61.

Polarean Imaging Share Discussion Threads

Showing 6476 to 6497 of 6500 messages
Chat Pages: 260  259  258  257  256  255  254  253  252  251  250  249  Older
DateSubjectAuthorDiscuss
17/4/2024
09:11
Aren’t they using Phillips sales force?
Also, surely the research hospitals’ contracts specify a fixed time period for deciding to go ahead on a commercial basis or return the technology to POLX?

wetdream
17/4/2024
08:18
New budget year started in January, makes you wonder what the Polarean sales force do all day, or perhaps they’re just not up to the job of selling expensive medical equipment. Clock continues to tick and the cash runway is coming to an end in 6 months. Look forward to seeing whether the CEO has the bottle to come to the UK this year for the AGM to face shareholders.
henley2
17/4/2024
08:10
If the technology is so great, why is it taking so long to convert the research centres to commercial terms? These centres are the early adopters of the technology and more than 15 months post FDA approval….NADAH!
henley2
16/4/2024
08:49
Got a jv in the wings for this . That's the next ingredient for real traction . what amazing technology!
moontheloon
16/4/2024
08:42
You can have all the patents and technology in the world but guess what you still need to make money via Commercialisation
nigelpm
16/4/2024
07:57
Time to hastily close the short bones. I'd take non invasive non radioactive in place of a wire up arm or leg into the right side of the heart any day of the week. Xenoview 129 just took a great step to expanding its coverage and uses. This thing will end up covering all sorts of conditions gas exchange is such a great area and is now suddenly quantifiable... visually. And they're protecting it rigidly. More to come on the trial and jv
moontheloon
16/4/2024
07:56
The market will disagree with you today...
sandy12345
16/4/2024
07:03
Patent granted for something hardly anybody is buying or using lol
bones698
12/4/2024
14:47
SP looking solid.
🤭

wetdream
11/4/2024
20:19
Is DES next to de list ?
amaretto1
11/4/2024
10:33
Https://www.frontiersin.org/articles/10.3389/fmed.2024.1342499/fullBastiaan is very busy and tells me in our regular interactions he is very excited about progress in 2024.Test results announced today.
moontheloon
11/4/2024
08:59
https://pubmed.ncbi.nlm.nih.gov/34478584/.... nothing to see here(not) ;)
moontheloon
10/4/2024
21:55
https://www.linkedin.com/posts/chrisvonjako_cluster-analysis-to-identify-long-covid-phenotypes-activity-7183869579364814849-hNs6?utm_source=share&utm_medium=member_android
moontheloon
10/4/2024
20:21
That is pure fantasy Gold.
nigelpm
10/4/2024
17:47
I hope you are correct Moontheloon.

DYTURBO 08/march on the other site speculates that Bracco and NUkem will put up funds for Polarean for rights to supply gas and selling rights in Europe.

The inference being it will not be in the form of dilution.
I cannot see that happening. Polarean should be considering it to avoid dilution.

Board of Directors with Bracco and effectively Nukem must be waiting on something if they waited so long
or are they playing UK shareholders.
The shares were over 27p when this CEO was brought in by the same Board of Directors

goldbutler
10/4/2024
15:27
It's a very well Informed reality. If you don't like the company for God's sake find a company you do for which you can devote positive energy
moontheloon
10/4/2024
15:19
If there was anything further that could be said it would have to be RNS'ed and certainly any confirmation of funding.

You're in a dream world.

nigelpm
10/4/2024
15:07
Fantasy in other words. A reminder from the RNS:

The Company is exploring the appropriate financing options, with an anticipated launch in Q2-2024

nigelpm
10/4/2024
15:01
Research dear boy.
moontheloon
10/4/2024
14:53
Based on what?
nigelpm
10/4/2024
11:43
Finance isn't in place - that's wrong.
nigelpm
10/4/2024
11:43
It's all incoming but never comes.
nigelpm
Chat Pages: 260  259  258  257  256  255  254  253  252  251  250  249  Older

Your Recent History

Delayed Upgrade Clock